 BOSTON, Dec. 23, 2020 GLOBE NEWSWIRE -- Ziopharm Oncology, Inc. Ziopharm or the Company Nasdaq: ZIOP, today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer of Ziopharm, is scheduled to participate in a fireside chat at the H.C. Wainwright Bioconnect 2021 Conference and will deliver a corporate overview at the 39th Annual J.P. Morgan Healthcare Conference. 